New insights into creatine transporter deficiency : Identification of neuropathological and metabolic targets for treatment
Creatine (Cr) transporter deficiency (CCDS1) is a very rare and severe condition due to impaired energetic metabolism. In this work we showed for the first time the following facts: this diseases is a progressive neurodegenerative disorder in which a set of maladaptive compensatory mechanisms leads...
Saved in:
Main Author: | Angelo Molinaro (auth) |
---|---|
Format: | Book Chapter |
Published: |
Firenze University Press
2020
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane Transporters and Channels as Targets for Drugs
Published: (2020) -
Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
Published: (2019) -
Charge Transport in DNA - Insights from Simulations
by: Wolter, Mario
Published: (2013) -
Drug Metabolism/Transport and Pharmacokinetics
Published: (2021) -
New Insights Into Metabolic Syndrome
Published: (2021)